Education
About Us
Working with TipRanks
Follow Us
Eli Lilly & Co (LLY)
NYSE:LLY
Total Valuation
Eli Lilly & Co has a market cap or net worth of $694.32B. The enterprise value is $761.80B.
Market Cap$694.32B
Enterprise Value$761.80B
Share Statistics
Eli Lilly & Co has 947.99M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding947.99M
Owened by Insiders10.30%
Owened by Instutions27.73%
Financial Efficiency
Eli Lilly & Co’s return on equity (ROE) is 0.74 and return on invested capital (ROIC) is 51.01%.
Return on Equity (ROE)73.95%
Return on Assets (ROA)13.45%
Return on Invested Capital (ROIC)51.01%
Return on Capital Employed (ROCE)25.62%
Revenue Per Employee$958,355.319
Profits Per Employee$225,319.149
Employee Count47,000
Asset Turnover0.57
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Eli Lilly & Co is 65.43. Eli Lilly & Co’s PEG ratio is 0.64.
PE Ratio65.43
PS Ratio15.38
PB Ratio48.38
Price to Fair Value48.38
Price to FCF1.67K
Price to Operating Cash Flow78.58
PEG Ratio0.64
Income Statement
In the last 12 months, Eli Lilly & Co had revenue of $45.04B and earned $10.59B in profits. Earnings per share was $11.74.
Revenue$45.04B
Gross Profit$36.76B
Operating Income$16.51B
Pretax Income$12.68B
Net Income$10.59B
EBITDA15.63B
Earnings Per Share (EPS)11.74
Cash Flow
In the last 12 months, operating cash flow was $8.82B and capital expenditures -$8.31B, giving a free cash flow of $510.80M billion.
Operating Cash Flow$8.82B
Free Cash Flow$510.80M
Free Cash Flow per Share$0.54
Dividends & Yields
Eli Lilly & Co pays an annual dividend of $1.50, resulting in a dividend yield of 0.74%
Dividend Per Share$1.50
Dividend Yield0.74%
Payout Ratio41.52%
Free Cash Flow Yield0.06%
Earnings Yield1.53%
Stock Price Statistics
Beta0.73
52-Week Price Change-1.81%
50-Day Moving Average839.43
200-Day Moving Average847.78
Relative Strength Index (RSI)39.44
Average Volume (3m)3.73M
Important Dates
Eli Lilly & Co upcoming earnings date is May 1, 2025, Before Open.
Last Earnings DateFeb 6, 2025
Next Earnings DateMay 1, 2025
Ex-Dividend DateFeb 14, 2025
Financial Position
Eli Lilly & Co as a current ratio of 0.12, with Debt / Equity ratio of 2.35
Current Ratio0.12
Quick Ratio0.12
Debt to Market Cap0.00
Net Debt to EBITDA1.99
Interest Coverage Ratio21.31
Taxes
In the past 12 months, Eli Lilly & Co has paid $2.09B in taxes.
Income Tax$2.09B
Effective Tax Rate16.49%
Enterprise Valuation
Eli Lilly & Co EV to EBITDA ratio is 47.50, with an EV/FCF ratio of 1.75K.
EV to Sales16.06
EV to EBITDA47.50
EV to Free Cash Flow1.75K
EV to Operating Cash Flow82.02
Balance Sheet
Eli Lilly & Co has $3.42B in cash and marketable securities with $33.64B in debt, giving a net cash position of $30.22B billion.
Cash & Marketable Securities$3.42B
Total Debt$33.64B
Net Cash$30.22B
Net Cash Per Share$31.88
Tangible Book Value Per Share$2.60
Margins
Gross margin is 81.31%, with operating margin of 28.64%, and net profit margin of 23.51%.
Gross Margin81.31%
Operating Margin28.64%
Pretax Margin28.15%
Net Profit Margin23.51%
EBITDA Margin33.81%
EBIT Margin29.88%
Analyst Forecast
The average price target for Eli Lilly & Co is $1038.21, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$1038.21
Price Target Upside41.75%
Analyst ConsensusStrong Buy
Analyst Count20
Revenue Growth Forecast32.00%
EPS Growth Forecast102.18%